Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Colorectal Neoplasms

  Free Subscription


Articles published in Cancer Lett

Retrieve available abstracts of 44 articles:
HTML format
Text format



Single Articles


    January 2019
  1. JIN F, Yang R, Wei Y, Wang D, et al
    HIF-1alpha-induced miR-23a approximately 27a approximately 24 cluster promotes colorectal cancer progression via reprogramming metabolism.
    Cancer Lett. 2019;440-441:211-222.
    PubMed     Text format     Abstract available


    October 2018
  2. DENG Q, Geng Y, Zhao L, Li R, et al
    NLRP3 inflammasomes in macrophages drive colorectal cancer metastasis to the liver.
    Cancer Lett. 2018;442:21-30.
    PubMed     Text format     Abstract available


  3. ZHANG YK, Wang YJ, Lei ZN, Zhang GN, et al
    Regorafenib antagonizes BCRP-mediated multidrug resistance in colon cancer.
    Cancer Lett. 2018 Oct 27. pii: S0304-3835(18)30647.
    PubMed     Text format     Abstract available


  4. ZHANG J, Ren P, Xu D, Liu X, et al
    Human UTP14a promotes colorectal cancer progression by forming a positive regulation loop with c-Myc.
    Cancer Lett. 2018 Oct 18. pii: S0304-3835(18)30624.
    PubMed     Text format     Abstract available


  5. LUO Y, Chen JJ, Lv Q, Qin J, et al
    Long non-coding RNA NEAT1 promotes colorectal cancer progression by competitively binding miR-34a with SIRT1 and enhancing the Wnt/beta-catenin signaling pathway.
    Cancer Lett. 2018 Oct 9. pii: S0304-3835(18)30606.
    PubMed     Text format     Abstract available


    September 2018
  6. WANG S, Xiao Z, Hong Z, Jiao H, et al
    FOXF1 promotes angiogenesis and accelerates bevacizumab resistance in colorectal cancer by transcriptionally activating VEGFA.
    Cancer Lett. 2018 Sep 22. pii: S0304-3835(18)30591.
    PubMed     Text format     Abstract available


    August 2018
  7. BELLAMKONDA K, Satapathy SR, Douglas D, Chandrashekar N, et al
    Montelukast, a CysLT1 receptor antagonist, reduces colon cancer stemness and tumor burden in a mouse xenograft model of human colon cancer.
    Cancer Lett. 2018 Aug 22. pii: S0304-3835(18)30531.
    PubMed     Text format     Abstract available


  8. TAN X, Zhang Z, Yao H, Shen L, et al
    Tim-4 promotes the growth of colorectal cancer by activating angiogenesis and recruiting tumor-associated macrophages via the PI3K/AKT/mTOR signaling pathway.
    Cancer Lett. 2018 Aug 14. pii: S0304-3835(18)30524.
    PubMed     Text format     Abstract available


  9. LIU Y, Yang EJ, Zhang B, Miao Z, et al
    PTEN deficiency confers colorectal cancer cell resistance to dual inhibitors of FLT3 and aurora kinase A.
    Cancer Lett. 2018 Aug 14. pii: S0304-3835(18)30523.
    PubMed     Text format     Abstract available


    July 2018
  10. HEIMER S, Knoll G, Steixner C, Calance DN, et al
    Hypertonicity-imposed BCL-XL addiction primes colorectal cancer cells for death.
    Cancer Lett. 2018;435:23-31.
    PubMed     Text format     Abstract available


  11. WU F, Liu F, Dong L, Yang H, et al
    miR-1273g silences MAGEA3/6 to inhibit human colorectal cancer cell growth via activation of AMPK signaling.
    Cancer Lett. 2018 Jul 26. pii: S0304-3835(18)30495.
    PubMed     Text format     Abstract available


  12. LIANG KH, Tso HC, Hung SH, Kuan II, et al
    Extracellular domain of EpCAM enhances tumor progression through EGFR signaling in colon cancer cells.
    Cancer Lett. 2018;433:165-175.
    PubMed     Text format     Abstract available


    June 2018
  13. HONG Y, Liew SC, Thean LF, Tang CL, et al
    Human colorectal cancer initiation is bidirectional, and cell growth, metabolic genes and transporter genes are early drivers of tumorigenesis.
    Cancer Lett. 2018;431:213-218.
    PubMed     Text format     Abstract available


    May 2018
  14. CHENG X, Feng H, Wu H, Jin Z, et al
    Targeting autophagy enhances apatinib-induced apoptosis via endoplasmic reticulum stress for human colorectal cancer.
    Cancer Lett. 2018;431:105-114.
    PubMed     Text format     Abstract available


  15. LI Y, Oliver PG, Lu W, Pathak V, et al
    Retraction notice to "SRI36160 is a specific inhibitor of Wnt/<beta>-catenin signaling in human pancreatic and colorectal cancer cells" [Canc. Lett. 389C (2017) 41-48].
    Cancer Lett. 2018;422:131.
    PubMed     Text format    


  16. LEE YH, Song NY, Suh J, Kim DH, et al
    Curcumin suppresses oncogenicity of human colon cancer cells by covalently modifying the cysteine 67 residue of SIRT1.
    Cancer Lett. 2018 May 25. pii: S0304-3835(18)30369.
    PubMed     Text format     Abstract available


  17. LI SZ, Zeng F, Li J, Shu QP, et al
    Nemo-like kinase (NLK) primes colorectal cancer progression by releasing the E2F1 complex from HDAC1.
    Cancer Lett. 2018;431:43-53.
    PubMed     Text format     Abstract available


    April 2018
  18. JIAN Y, Wang M, Zhang Y, Ou R, et al
    Jade family PHD finger 3 (JADE3) increases cancer stem cell-like properties and tumorigenicity in colon cancer.
    Cancer Lett. 2018 Apr 13. pii: S0304-3835(18)30273.
    PubMed     Text format     Abstract available


  19. SONG J, Wang T, Xu W, Wang P, et al
    HOXB9 acetylation at K27 is responsible for its suppression of colon cancer progression.
    Cancer Lett. 2018 Apr 11. pii: S0304-3835(18)30263.
    PubMed     Text format     Abstract available


    March 2018
  20. JIANG H, Li T, Qu Y, Wang X, et al
    Long non-coding RNA SNHG15 interacts with and stabilizes transcription factor Slug and promotes colon cancer progression.
    Cancer Lett. 2018 Mar 28. pii: S0304-3835(18)30241.
    PubMed     Text format     Abstract available


  21. BASU S, Gavert N, Brabletz T, Ben-Ze'ev A, et al
    The intestinal stem cell regulating gene ASCL2 is required for L1-mediated colon cancer progression.
    Cancer Lett. 2018 Mar 15. pii: S0304-3835(18)30219.
    PubMed     Text format     Abstract available


  22. TAN K, Leong SM, Kee Z, Caramat PV, et al
    Longitudinal monitoring reveals dynamic changes in circulating tumor cells (CTCs) and CTC-associated miRNAs in response to chemotherapy in metastatic colorectal cancer patients.
    Cancer Lett. 2018 Mar 5. pii: S0304-3835(18)30180.
    PubMed     Text format     Abstract available


    February 2018
  23. BAE WK, Hong CS, Park MR, Sun EG, et al
    TAp73 inhibits cell invasion and migration by directly activating KAI1 expression in colorectal carcinoma.
    Cancer Lett. 2018;415:106-116.
    PubMed     Text format     Abstract available


  24. AL-HAIDARI A, Algaber A, Madhi R, Syk I, et al
    MiR-155-5p controls colon cancer cell migration via post-transcriptional regulation of Human Antigen R (HuR).
    Cancer Lett. 2018;421:145-151.
    PubMed     Text format     Abstract available


  25. SHUAI W, Wu J, Chen S, Liu R, et al
    SUV39H2 promotes colorectal cancer proliferation and metastasis via tri-methylation of the SLIT1 promoter.
    Cancer Lett. 2018 Feb 16. pii: S0304-3835(18)30156.
    PubMed     Text format     Abstract available


  26. OU C, Sun Z, Li X, Li X, et al
    Corrigendum to "MiR-590-5p, a density-sensitive microRNA, inhibits tumorigenesis by targeting YAP1 in colorectal cancer", [Canc. Lett. 399 (2017) 53-63].
    Cancer Lett. 2018 Feb 8. pii: S0304-3835(18)30106.
    PubMed     Text format    


  27. GRUNDEMANN C, Huber R
    Chemoprevention with isothiocyanates - From bench to bedside.
    Cancer Lett. 2018;414:26-33.
    PubMed     Text format     Abstract available


    January 2018
  28. PORCELLINI E, Laprovitera N, Riefolo M, Ravaioli M, et al
    Epigenetic and epitranscriptomic changes in colorectal cancer: diagnostic, prognostic, and treatment implications.
    Cancer Lett. 2018 Jan 19. pii: S0304-3835(18)30071.
    PubMed     Text format     Abstract available


  29. ZHANG S, Hu B, You Y, Yang Z, et al
    Sorting nexin 10 acts as a tumor suppressor in tumorigenesis and progression of colorectal cancer through regulating chaperone mediated autophagy degradation of p21(Cip1/WAF1).
    Cancer Lett. 2018 Jan 17. pii: S0304-3835(18)30067.
    PubMed     Text format     Abstract available


  30. KIM T, Croce CM
    Long noncoding RNAs: Undeciphered cellular codes encrypting keys of colorectal cancer pathogenesis.
    Cancer Lett. 2018 Jan 3. pii: S0304-3835(18)30006.
    PubMed     Text format     Abstract available


    December 2017
  31. KIM CW, Oh ET, Kim JM, Park JS, et al
    Hypoxia-induced microRNA-590-5p promotes colorectal cancer progression by modulating matrix metalloproteinase activity.
    Cancer Lett. 2017;416:31-41.
    PubMed     Text format     Abstract available


  32. BYUN MR, Hwang JH, Kim AR, Kim KM, et al
    SRC activates TAZ for intestinal tumorigenesis and regeneration.
    Cancer Lett. 2017;410:32-40.
    PubMed     Text format     Abstract available


  33. FANG Z, Gong C, Yu S, Zhou W, et al
    NFYB-induced high expression of E2F1 contributes to oxaliplatin resistance in colorectal cancer via the enhancement of CHK1 signaling.
    Cancer Lett. 2017 Dec 1. pii: S0304-3835(17)30765.
    PubMed     Text format     Abstract available


    November 2017
  34. BLEAU AM, Redrado M, Nistal-Villan E, Villalba M, et al
    miR-146a targets c-met and abolishes colorectal cancer liver metastasis.
    Cancer Lett. 2017 Nov 10. pii: S0304-3835(17)30702.
    PubMed     Text format     Abstract available


    October 2017
  35. KIM C, Hong Y, Lee H, Kang H, et al
    MicroRNA-195 Desensitizes HCT116 Human Colon Cancer Cells to 5-Fluorouracil.
    Cancer Lett. 2017 Oct 25. pii: S0304-3835(17)30659.
    PubMed     Text format     Abstract available


  36. ZHUGE W, Chen R, Vladimir K, Dong X, et al
    Costunolide specifically binds and inhibits thioredoxin reductase 1 to induce apoptosis in colon cancer.
    Cancer Lett. 2017 Oct 13. pii: S0304-3835(17)30630.
    PubMed     Text format     Abstract available


  37. LIANG Z, Yang Y, He Y, Yang P, et al
    SUMOylation of IQGAP1 promotes the development of colorectal cancer.
    Cancer Lett. 2017 Oct 5. pii: S0304-3835(17)30607.
    PubMed     Text format     Abstract available


  38. SHUKLA K, Sonowal H, Saxena A, Ramana KV, et al
    Aldose reductase inhibitor, fidarestat regulates mitochondrial biogenesis via Nrf2/HO1/AMPK pathway in colon cancer cells.
    Cancer Lett. 2017 Oct 3. pii: S0304-3835(17)30584.
    PubMed     Text format     Abstract available


    September 2017
  39. FANG C, Qiu S, Sun F, Li W, et al
    Long non-coding RNA HNF1A-AS1 mediated repression of miR-34a/SIRT1/p53 feedback loop promotes the metastatic progression of colon cancer by functioning as a competing endogenous RNA.
    Cancer Lett. 2017 Sep 21. pii: S0304-3835(17)30562.
    PubMed     Text format     Abstract available


  40. YAGDI EFE E, Mazumder A, Lee JY, Gaigneaux A, et al
    Tubulin-binding anticancer polysulfides induce cell death via mitotic arrest and autophagic interference in colorectal cancer.
    Cancer Lett. 2017 Sep 21. pii: S0304-3835(17)30561.
    PubMed     Text format     Abstract available


  41. LI W, Qiu T, Guo L, Ying J, et al
    Major challenges related to tumor biological characteristics in accurate mutation detection of colorectal cancer by next-generation sequencing.
    Cancer Lett. 2017 Sep 21. pii: S0304-3835(17)30564.
    PubMed     Text format     Abstract available


  42. SUN LN, Zhi Z, Chen LY, Zhou Q, et al
    SIRT1 suppresses colorectal cancer metastasis by transcriptional repression of miR-15b-5p.
    Cancer Lett. 2017 Sep 15. pii: S0304-3835(17)30548.
    PubMed     Text format     Abstract available


  43. RADHAKRISHNAN H, Ilm K, Walther W, Shirasawa S, et al
    MACC1 regulates Fas mediated apoptosis through STAT1/3 - Mcl-1 signaling in solid cancers.
    Cancer Lett. 2017;403:231-245.
    PubMed     Text format     Abstract available


  44. WESTDORP H, Kolders S, Hoogerbrugge N, de Vries IJM, et al
    Immunotherapy holds the key to cancer treatment and prevention in constitutional mismatch repair deficiency (CMMRD) syndrome.
    Cancer Lett. 2017;403:159-164.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: